Trastuzumab deruxtecan versus treatment of physician's choice in patients with HER2-positive metastatic breast cancer (DESTINY-Breast02): a randomised, open-label, multicentre, phase 3 trial
Resource Type
Article
Authors
André, Fabrice ; Hee Park, Yeon ; Kim, Sung-Bae ; Takano, Toshimi ; Im, Seock-Ah ; Borges, Giuliano ; Lima, Joao Paulo ; Aksoy, Sercan ; Gavila Gregori, Joaquin ; De Laurentiis, Michelino ; Bianchini, Giampaolo ; Roylance, Rebecca ; Miyoshi, Yasuo ; Armstrong, Anne ; Sinha, Rajni ; Ruiz Borrego, Manuel ; Lim, Elgene ; Ettl, Johannes ; Yerushalmi, Rinat ; Zagouri, Flora ; Duhoux, Francois P ; Fehm, Tanja ; Gambhire, Dhiraj ; Cathcart, Jillian ; Wu, Cai ; Chu, Changan ; Egorov, Anton ; Krop, Ian
Source
In The Lancet 27 May-2 June 2023 401(10390):1773-1785
Subject
Primary Research Articles
Language
ISSN
0140-6736